» Articles » PMID: 36969223

Associations Between Bullous Pemphigoid and Hematological Diseases: Literature Review on Mechanistic Connections and Possible Treatments

Overview
Journal Front Immunol
Date 2023 Mar 27
PMID 36969223
Authors
Affiliations
Soon will be listed here.
Abstract

Bullous pemphigoid is an autoimmune blistering disorder that primarily occurs in elderly patients. Reports indicate that BP coexists with various hematological diseases, including acquired hemophilia A, hypereosinophilic syndrome, aplastic anemia, autoimmune thrombocytopenia, and hematological malignancies. Early identification of these comorbidities contributes to a better control and reduced mortality. This article details the atypical clinical manifestations of BP when associated with hematological diseases, specific diagnostic strategies, underlying mechanistic connections, and possible treatments. Cross-reactivity between autoantibodies and exposed abnormal epitopes, shared cytokines and immune cells, together with genetic susceptibility are the most common connections between BP and hematological diseases. Patients were most often successfully treated with oral steroids combined with medications specifically targeting the hematological disorders. However, the individual comorbidities require specific considerations.

Citing Articles

Bullous pemphigoid.

Akbarialiabad H, Schmidt E, Patsatsi A, Lim Y, Mosam A, Tasanen K Nat Rev Dis Primers. 2025; 11(1):12.

PMID: 39979318 DOI: 10.1038/s41572-025-00595-5.


Single cell transcriptome profiling reveals pathogenesis of bullous pemphigoid.

Liang G, Zhao C, Wei Q, Feng S, Wang Y Commun Biol. 2025; 8(1):203.

PMID: 39922909 PMC: 11807148. DOI: 10.1038/s42003-025-07629-4.


Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.

Iovene F, Santinelli E, Armiento D, Sarlo C, Bancone C, Silvestri L Ann Hematol. 2024; 103(7):2545-2549.

PMID: 38780802 DOI: 10.1007/s00277-024-05804-x.

References
1.
Saouli Z, Papadopoulos A, Kaiafa G, Girtovitis F, Kontoninas Z . A new approach on bullous pemphigoid therapy. Ann Oncol. 2008; 19(4):825-6. DOI: 10.1093/annonc/mdn046. View

2.
Sourdeau E, Clauser S, Prudhomme R, Bardet V, Calmette L . [Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report]. Ann Biol Clin (Paris). 2019; 77(2):179-183. DOI: 10.1684/abc.2018.1405. View

3.
Misery L, Cambazard F, Rimokh R, Ghohestani R, Magaud J, Gaudillere A . Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells. Br J Dermatol. 1999; 141(1):155-7. DOI: 10.1046/j.1365-2133.1999.02940.x. View

4.
Ivars M, Hashimoto T, Ishii N, Bernad I, Lecumberri R, Espana A . Atypical bullous pemphigoid with extensive cutaneous and mucosal erosions associated with chronic lymphocytic leukemia. J Dermatol. 2015; 42(11):1128-9. DOI: 10.1111/1346-8138.13067. View

5.
Bakchoul T, Marini I . Drug-associated thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2018; 2018(1):576-583. PMC: 6246020. DOI: 10.1182/asheducation-2018.1.576. View